Can Testosterone, HCG, And Masteron Be Sustainable Long Term?
Timeline
Timestamp
Topic
00:00
A 28-year-old man describes using testosterone, HCG, and Masteron together and asks whether the regimen can remain sustainable for decades.
06:14
Dr. O’Connor discusses his own past use of very low-dose Masteron and explains why product quality, medical oversight, and health monitoring matter.
08:37
Testosterone and HCG are examined together, including HPG-axis suppression, cognitive effects, estradiol production, aromatization, body fat, and possible HCG dose reduction.
14:09
Dr. O’Connor explains why some men add Masteron to TRT and HCG and explores its perceived anti-estrogenic effects compared with traditional estrogen-control drugs.
23:49
The discussion shifts to HCG tolerance, receptor downregulation, fertility after steroid exposure, and why long-term fertility management may require changing the regimen.
28:19
Dr. O’Connor closes with Masteron sustainability, underground drug quality, ABCDs™ monitoring, blood pressure, cardiovascular and kidney health, sexual function, and diminishing returns.
Video Summary
A 28-year-old man asks whether his testosterone, HCG, and Masteron regimen can remain sustainable for decades. Dr. Thomas O’Connor reviews why the combination makes him feel better, including improved mood, cognition, sexual function, and control of estrogen-related symptoms, while questioning whether all three compounds are necessary long term.
The discussion focuses on how testosterone and HCG can increase estrogenic effects, why some men add DHT-derived steroids such as Masteron, and the limited scientific evidence supporting this approach. Dr. O’Connor explains that Masteron may produce tissue-level anti-estrogenic effects without functioning like a traditional aromatase inhibitor.
Long-term health remains the primary concern. Dr. O’Connor discusses HCG tolerance and downregulation, fertility, cardiovascular and kidney monitoring, blood pressure, erectile function, mood, and the potential for diminishing returns from continued androgen use. His broader message is to minimize unnecessary variables, continually reassess the regimen, and closely monitor the ABCDs™ and other markers of long-term health.
Drug Callouts
Drug
Description
Testosterone Cypionate
The patient uses prescribed testosterone cypionate as the foundation of his TRT regimen and divides his weekly dose into three injections. Testosterone cypionate is a long-acting injectable testosterone formulation used for testosterone replacement and can suppress the hypothalamic-pituitary-gonadal axis while also increasing estradiol through aromatization.
Human Chorionic Gonadotropin (HCG)
HCG is used with testosterone because the patient reports better cognitive function, although he also associates it with increased estradiol, bloating, anxiety, and mood changes. HCG acts similarly to luteinizing hormone at the testes and is commonly used in men on testosterone when preservation of testicular function or fertility is an important consideration.
Masteron (Drostanolone)
The patient adds Masteron to his testosterone and HCG because he reports better mood, resilience, sexual function, and fewer estrogen-related symptoms. Drostanolone is a DHT-derived anabolic-androgenic steroid that does not aromatize to estrogen, but long-term use may still carry cardiovascular, lipid, hormonal, and other androgen-related risks.
Anastrozole
Dr. O’Connor discusses anastrozole while comparing traditional aromatase inhibition with the different effects men report from Masteron. Anastrozole blocks the aromatase enzyme and can substantially reduce estradiol, which is why excessive suppression can create sexual, musculoskeletal, metabolic, and cardiovascular concerns in men on testosterone.
Tamoxifen
Tamoxifen is discussed as an example of a selective estrogen receptor modulator when Dr. O’Connor explains possible tissue-level estrogen receptor effects. In men using testosterone or anabolic steroids, tamoxifen is sometimes used clinically to block estrogen activity in breast tissue, particularly when gynecomastia is a concern.
Clomiphene
Clomiphene is discussed in the context of restoring or supporting fertility after testosterone or substantial anabolic-steroid exposure. It is a selective estrogen receptor modulator that can stimulate endogenous gonadotropin signaling, although response may vary considerably in men whose reproductive axis has been suppressed for long periods.
Condition Callouts
Condition
Description
Elevated Estradiol and Estrogenic Symptoms
The patient reports bloating, anxiety, and mood changes that he attributes to higher estradiol while combining testosterone with HCG. Men on testosterone can experience increased estradiol through aromatization, and individual symptoms and laboratory responses can vary substantially with dose, body composition, HCG use, and personal biology.
Gynecomastia
Gynecomastia is discussed as a possible estrogen-sensitive tissue effect associated with testosterone, HCG, and other hormonal regimens. In men using testosterone or anabolic steroids, an imbalance between androgenic and estrogenic signaling can stimulate breast gland tissue and produce tenderness or enlargement.
Hypogonadotropic Suppression and Fertility Impairment
Dr. O’Connor repeatedly addresses suppression of the reproductive axis and the possibility that prolonged steroid exposure can make fertility restoration more difficult. Exogenous testosterone and anabolic steroids suppress LH and FSH signaling, which can reduce intratesticular testosterone, sperm production, testicular volume, and fertility.
Hypertension
Blood pressure is highlighted as one of the most important measurements for a man planning decades of testosterone or androgen use. Testosterone and anabolic steroids can contribute to blood-pressure problems in susceptible men through effects involving fluid balance, vascular function, body weight, and the renin-angiotensin-aldosterone system.
Erectile Dysfunction
Dr. O’Connor describes erectile dysfunction as a problem he has seen when hormonal regimens become unstable or after men discontinue certain anabolic steroids. In men using testosterone and other androgens, erectile function can be influenced by estradiol balance, vascular health, psychological state, medication effects, and changes in androgen exposure.
Mood and Anxiety Symptoms
Mood, anxiety, resilience, and cognitive function are central to the patient’s reasons for using HCG and Masteron alongside testosterone. Men using testosterone or anabolic steroids can experience changes in mood and anxiety when androgen or estrogen exposure changes, especially during dose adjustments, withdrawal, or complex multi-drug regimens.
Key Takeaways
- Testosterone is the foundation of this patient’s regimen, while HCG and Masteron are the two variables Dr. O’Connor believes deserve continued reassessment.
- The patient reports meaningful benefits from HCG and Masteron, but feeling better does not by itself establish that the combination is safe or sustainable for decades.
- Testosterone plus HCG may increase estrogenic effects in some men, particularly when HCG doses are higher or aromatization is increased.
- Dr. O’Connor distinguishes Masteron’s perceived anti-estrogenic effects from traditional aromatase inhibitors and emphasizes that strong randomized clinical evidence is lacking.
- Long-term HCG use is discussed in the context of tolerance, receptor downregulation, testicular responsiveness, and future fertility rather than as a guaranteed permanent solution.
- For long-term androgen users, Dr. O’Connor repeatedly emphasizes ABCDs™ monitoring, blood pressure, cardiovascular and kidney health, sexual function, mental health, and reducing unnecessary drug exposure.